FindTrial
Sign In

evaluation of effect of inhalational anesthestic sevoflurane on funtions of right side of heart using echocardiography during cardiac surgery.

Evaluation of effect of sevoflurane on right ventricular contractile function using transesophageal echocardiography during cardiac surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053799
Enrollment
40
Registered
2023-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: sevoflurane inhalational anaesthetic agent: sevoflurane administered in different concentrations(1, 1.5 and 2 MAC) for 15 minutes Control Intervention1: Tricuspid plane annular systolic

Sponsors

Aseem Gargava
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: posted for cardiac surgery requiring transesophageal echocardiography

Exclusion criteria

Exclusion criteria: pacemaker implantation, atrial fibrillation, right ventricular dysfunction, moderate to severe pulmonary hypertension, organic tricuspid valve dysfunction, cardiac tamponade or any other contraindication for tranesophageal echocardiography.

Design outcomes

Primary

MeasureTime frame
tricuspid plane annular systolic excursion(TAPSE) rise in mmTimepoint: 5 minutes after different inhalation anesthetic concentrations are achieved(1, 1.5, 2 MAC)—

Secondary

MeasureTime frame
Right ventricular ejection fractionTimepoint: 5 minutes after different inhalation anesthetic concentrations is achieved(1, 1.5, 2 MAC);Right ventricular systolic pressureTimepoint: 5 minutes after different inhalation anesthetic concentrations is achieved(1, 1.5, 2 MAC)—

Countries

India

Contacts

Public ContactAseem Gargava

Gandhi medical college bhopal

aseemgargava@gmail.com8860494714

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026